Epitalon vs Pinealon: Comparing the Indexed Record
Researchers comparing Epitalon and Pinealon are usually resolving one question: which compound the published record actually supports for the model in front of them.
Compound profiles
Epitalon in the indexed record
Indexed output for Epitalon stands at 62 records, a moderate literature with no registered studies currently listed on ClinicalTrials.gov.
Publications carrying this compound include Aging (Albany NY), Biogerontology, Int J Mol Sci, spanning 2002–2025.
- Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — Int J Mol Sci, 2025. PMID: 40141333
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — Biogerontology, 2025. PMID: 40908429
- Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro — Aging (Albany NY), 2022. PMID: 35413689
- The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy — Stem Cell Rev Rep, 2025. PMID: 40493162
Pinealon in the indexed record
Searching Pinealon against the PubMed index returns 22 records, a limited evidence base with no registered studies currently listed on ClinicalTrials.gov.
Journals represented in the current index include Adv Gerontol, Int J Clin Exp Med, J Am Acad Orthop Surg Glob Res Rev, spanning 2008–2026.
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- Pinealon protects the rat offspring from prenatal hyperhomocysteinemia — Int J Clin Exp Med, 2012. PMID: 22567179
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes — Rejuvenation Res, 2011. PMID: 21978084
- [Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia] — Adv Gerontol, 2015. PMID: 28509493
How the literature differs
The indexed record is not symmetrical between these two compounds. Epitalon carries 40 more indexed records than Pinealon, which means published methodology, characterisation data and replication attempts are more readily located for Epitalon. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (0 vs 0) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Side-by-side research profile
| Parameter | Epitalon | Pinealon |
|---|---|---|
| PubMed indexed records | 62 | 22 |
| Registered studies (ClinicalTrials.gov) | 0 | 0 |
| Literature depth | Moderate | Emerging |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
Epitalon and Pinealon sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for Epitalon describes conditions validated for Epitalon: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Pinealon without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
Storage and stability
Lyophilised peptide is the stable form. Held sealed at -20°C and shielded from light, it tolerates long storage; once reconstituted that tolerance drops sharply and the working solution is treated as short-lived.
Each freeze-thaw cycle costs integrity, which is why reconstituted material is normally split into single-use aliquots.
Selecting between them for a study design
Epitalon and Pinealon are not interchangeable. They differ in structural class and in the pathways the literature associates with each, so substituting one for the other changes what a model is actually measuring.
Where a protocol cites a specific compound, the cited compound is the one the published result applies to. Where no protocol exists, the compound with the deeper indexed record (Epitalon) generally offers more methodological precedent.
Frequently asked questions
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
What is the regulatory status of these compounds?
Neither is an approved drug. Both are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary consumption.
Are Epitalon and Pinealon the same compound?
No. They are structurally distinct research compounds with separate literature records — 62 indexed records for Epitalon and 22 for Pinealon.
Which of Epitalon or Pinealon has more published research?
Epitalon, with 62 indexed PubMed records against 22.
Related references
- Epitalon — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.